Søgeord

Søgning på udtrykket 'herpes zoster' giver 7 resultater

Nyt fra tidsskrifterne [7]

Nyt fra tidsskrifterne [7]

Journal of Medical Virology
29.04.2021
Journal of Medical Virology, Accepted Article.
BMJ Open
25.03.2021
Objectives To assess the safety of live attenuated herpes zoster vaccine live (ZVL) through cumulative analysis of near real-time, participant-based active surveillance from Australia’s AusVaxSafety system. Design and setting ZVL was funded in Australia for adults aged 70 years from November 2016, with a time-limited catch up programme for those up to 79 years. This cohort study monitored safety in the first two programme years through active surveillance at 246 sentinel surveillance immunisation si…
International Journal of Infectious Diseases
10.02.2021
Herpes zoster is a disease caused by reactivation of varicella zoster virus (VZV). After the primary infection (varicella), VZV remains dormant in the sympathetic, enteric, dorsal root and cranial nerve ganglia for up to several decades (Kennedy, Gershon 2018). Reactivation in the form of herpes zoster may occur spontaneously or in the context of impaired cell-mediated immunity, such as HIV/AIDS, chronic lymphocytic leukaemia (CLL), Hodgkin™s and non-Hodgkin™s lymphomas, prolonged systemic corticosteroi…
Clinical Infectious Diseases
9.03.2020
AbstractBackgroundCord blood transplant (CBT) recipients have a high incidence of herpes zoster (HZ) in the context of short-term peritransplant antiviral prophylaxis. In 2009, international guidelines recommended HZ prophylaxis for at least 1 year after hematopoietic cell transplant. The impact of longer-term antiviral prophylaxis on HZ incidence after CBT is unknown.MethodsWe retrospectively analyzed varicella zoster virus (VZV)-seropositive CBT recipients who were transplanted between 2006 and 2016. We a…
BMJ Open
25.03.2021
Objectives To assess the safety of live attenuated herpes zoster vaccine live (ZVL) through cumulative analysis of near real-time, participant-based active surveillance from Australia’s AusVaxSafety system. Design and setting ZVL was funded in Australia for adults aged 70 years from November 2016, with a time-limited catch up programme for those up to 79 years. This cohort study monitored safety in the first two programme years through active surveillance at 246 sentinel surveillance immunisation si…
International Journal of Infectious Diseases
10.02.2021
Herpes zoster is a disease caused by reactivation of varicella zoster virus (VZV). After the primary infection (varicella), VZV remains dormant in the sympathetic, enteric, dorsal root and cranial nerve ganglia for up to several decades (Kennedy, Gershon 2018). Reactivation in the form of herpes zoster may occur spontaneously or in the context of impaired cell-mediated immunity, such as HIV/AIDS, chronic lymphocytic leukaemia (CLL), Hodgkin™s and non-Hodgkin™s lymphomas, prolonged systemic corticosteroi…
Clinical Infectious Diseases
9.03.2020
AbstractBackgroundCord blood transplant (CBT) recipients have a high incidence of herpes zoster (HZ) in the context of short-term peritransplant antiviral prophylaxis. In 2009, international guidelines recommended HZ prophylaxis for at least 1 year after hematopoietic cell transplant. The impact of longer-term antiviral prophylaxis on HZ incidence after CBT is unknown.MethodsWe retrospectively analyzed varicella zoster virus (VZV)-seropositive CBT recipients who were transplanted between 2006 and 2016. We a…

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2021 Dansk Selskab for Infektionsmedicin

version: 2.9.0 ● design: C P Fischer

Side indlæst på 0,613 s

Cookies og privatliv